TMO vs CI
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | CI |
|---|---|---|
| Price | $700.22 | $297.00 |
| Market cap | $259.44B | $78.26B |
| P/E ratio | 36.9 | 13.1 |
| ROE | 13.38% | 15.65% |
| Profit margin | 14.94% | 2.09% |
| Revenue growth | 9.10% | 5.60% |
| Dividend yield | 0.27% | 2.10% |
| Beta | 0.84 | 0.25 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs CI in plain English
- TMO is the bigger company — about 3.3× the market cap of CI.
- CI is cheaper on earnings (P/E 13.1 vs 36.9).
- CI earns a higher return on equity (16% vs 13%).
- TMO is growing revenue faster (9% vs 6%).
- CI has the higher dividend yield (2.10% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.